Mineralys

Mineralys Therapeutics is a clinical-stage firm developing an aldosterone synthase inhibitor to treat hypertension and chronic kidney/​heart disease.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2023
Stage of Initial Investment
Series B
Initial Investment Year
2022